641 related articles for article (PubMed ID: 33525415)
1. Chloroquine and Hydroxychloroquine Interact Differently with ACE2 Domains Reported to Bind with the Coronavirus Spike Protein: Mediation by ACE2 Polymorphism.
Badraoui R; Adnan M; Bardakci F; Alreshidi MM
Molecules; 2021 Jan; 26(3):. PubMed ID: 33525415
[TBL] [Abstract][Full Text] [Related]
2. In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection.
Braz HLB; Silveira JAM; Marinho AD; de Moraes MEA; Moraes Filho MO; Monteiro HSA; Jorge RJB
Int J Antimicrob Agents; 2020 Sep; 56(3):106119. PubMed ID: 32738306
[TBL] [Abstract][Full Text] [Related]
3. Chloroquine and hydroxychloroquine as ACE2 blockers to inhibit viropexis of 2019-nCoV Spike pseudotyped virus.
Wang N; Han S; Liu R; Meng L; He H; Zhang Y; Wang C; Lv Y; Wang J; Li X; Ding Y; Fu J; Hou Y; Lu W; Ma W; Zhan Y; Dai B; Zhang J; Pan X; Hu S; Gao J; Jia Q; Zhang L; Ge S; Wang S; Liang P; Hu T; Lu J; Wang X; Zhou H; Ta W; Wang Y; Lu S; He L
Phytomedicine; 2020 Dec; 79():153333. PubMed ID: 32920291
[TBL] [Abstract][Full Text] [Related]
4. Epigallocatechin gallate and theaflavin gallate interaction in SARS-CoV-2 spike-protein central channel with reference to the hydroxychloroquine interaction: Bioinformatics and molecular docking study.
Maiti S; Banerjee A
Drug Dev Res; 2021 Feb; 82(1):86-96. PubMed ID: 32770567
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the Modulatory Effect of Hydroxychloroquine on ACE2 Activity: New Insights in relation to COVID-19.
Tichauer JE; Soto D; Andresen M
Biomed Res Int; 2021; 2021():6614000. PubMed ID: 34337036
[TBL] [Abstract][Full Text] [Related]
6. Cell membrane chromatography for the analysis of the interaction between chloroquine and hydroxychloroquine with ACE2 receptors.
Fu J; Jia Q; Zhou H; Zhang L; Wang S; Liang P; Lv Y; Han S
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jan; 1162():122469. PubMed ID: 33310480
[TBL] [Abstract][Full Text] [Related]
7. Analogue discovery of safer alternatives to HCQ and CQ drugs for SAR-CoV-2 by computational design.
Sinha M; Gupta A; Gupta S; Singh P; Pandit S; Chauhan SS; Parthasarathi R
Comput Biol Med; 2021 Mar; 130():104222. PubMed ID: 33535144
[TBL] [Abstract][Full Text] [Related]
8. Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike protein.
Calcagnile M; Forgez P; Iannelli A; Bucci C; Alifano M; Alifano P
Biochimie; 2021 Jan; 180():143-148. PubMed ID: 33181224
[TBL] [Abstract][Full Text] [Related]
9. Approach to the mechanism of action of hydroxychloroquine on SARS-CoV-2: a molecular docking study.
Celı K I; Onay-Besı Kcı A; Ayhan-Kilcigı L G
J Biomol Struct Dyn; 2021 Sep; 39(15):5792-5798. PubMed ID: 32677545
[TBL] [Abstract][Full Text] [Related]
10. In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs.
Choudhury A; Mukherjee S
J Med Virol; 2020 Oct; 92(10):2105-2113. PubMed ID: 32383269
[TBL] [Abstract][Full Text] [Related]
11. Investigating interactions between chloroquine/hydroxychloroquine and their single enantiomers and angiotensin-converting enzyme 2 by a cell membrane chromatography method.
Jia Q; Fu J; Liang P; Wang S; Wang Y; Zhang X; Zhou H; Zhang L; Lv Y; Han S
J Sep Sci; 2022 Jan; 45(2):456-467. PubMed ID: 34729910
[TBL] [Abstract][Full Text] [Related]
12. Chloroquine and hydroxychloroquine in the treatment of COVID-19: the never-ending story.
Gasmi A; Peana M; Noor S; Lysiuk R; Menzel A; Gasmi Benahmed A; Bjørklund G
Appl Microbiol Biotechnol; 2021 Feb; 105(4):1333-1343. PubMed ID: 33515285
[TBL] [Abstract][Full Text] [Related]
13. Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2.
Suryamohan K; Diwanji D; Stawiski EW; Gupta R; Miersch S; Liu J; Chen C; Jiang YP; Fellouse FA; Sathirapongsasuti JF; Albers PK; Deepak T; Saberianfar R; Ratan A; Washburn G; Mis M; Santhosh D; Somasekar S; Hiranjith GH; Vargas D; Mohan S; Phalke S; Kuriakose B; Antony A; Ustav M; Schuster SC; Sidhu S; Junutula JR; Jura N; Seshagiri S
Commun Biol; 2021 Apr; 4(1):475. PubMed ID: 33846513
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 Pandemic - A Narrative Review of the Potential Roles of Chloroquine and Hydroxychloroquine.
de Barros CM; Almeida CAF; Pereira B; Costa KCM; Pinheiro FA; Maia LDB; Trindade CM; Garcia RCT; Torres LH; Diwan S; Boralli VB
Pain Physician; 2020 Aug; 23(4S):S351-S366. PubMed ID: 32942793
[TBL] [Abstract][Full Text] [Related]
15. Autophagy as an emerging target for COVID-19: lessons from an old friend, chloroquine.
Bonam SR; Muller S; Bayry J; Klionsky DJ
Autophagy; 2020 Dec; 16(12):2260-2266. PubMed ID: 32522067
[TBL] [Abstract][Full Text] [Related]
16. Withanone from
Balkrishna A; Pokhrel S; Singh H; Joshi M; Mulay VP; Haldar S; Varshney A
Drug Des Devel Ther; 2021; 15():1111-1133. PubMed ID: 33737804
[TBL] [Abstract][Full Text] [Related]
17. A potential antiviral activity of Esculentoside A against binding interactions of SARS-COV-2 spike protein and angiotensin converting enzyme 2 (ACE2).
Zeng MS; Yu WD; Wang HX; Liu JY; Xu PP
Int J Biol Macromol; 2021 Jul; 183():2248-2261. PubMed ID: 34111482
[TBL] [Abstract][Full Text] [Related]
18. Diversity of ACE2 and its interaction with SARS-CoV-2 receptor binding domain.
Low-Gan J; Huang R; Kelley A; Jenkins GW; McGregor D; Smider VV
Biochem J; 2021 Oct; 478(19):3671-3684. PubMed ID: 34558627
[TBL] [Abstract][Full Text] [Related]
19. Susceptibilities of Human ACE2 Genetic Variants in Coronavirus Infection.
Ren W; Zhu Y; Lan J; Chen H; Wang Y; Shi H; Feng F; Chen DY; Close B; Zhao X; Wu J; Tian B; Yuan Z; Zhou D; Saeed M; Wang X; Zhang R; Ding Q
J Virol; 2022 Jan; 96(1):e0149221. PubMed ID: 34668773
[TBL] [Abstract][Full Text] [Related]
20. Shedding Light on the Inhibitory Mechanisms of SARS-CoV-1/CoV-2 Spike Proteins by ACE2-Designed Peptides.
Freitas FC; Ferreira PHB; Favaro DC; Oliveira RJ
J Chem Inf Model; 2021 Mar; 61(3):1226-1243. PubMed ID: 33619962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
